Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMA II: Optimizing Prograf Therapy in Maintenance Allografts
NCT00905515Phase 4Completed
- Sponsor
- East Carolina University
- Start
- Aug 2003
- Primary completion
- Jul 2008
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by East Carolina University. Started Aug 2003; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00905515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00905515.